International Zinc Association Partners With Pharmanova to Save Children in Zambia
21.1.2026 09:00:00 CET | Business Wire | Press release
Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA), has announced a new partnership with leading Zambian pharmaceutical manufacturer Pharmanova Zambia Limited to expand access to life‑saving zinc treatments for children across Zambia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121178091/en/

Life-saving zinc-supplementation and oral rehydration salts kits are proactively distributed to Zambian children through the works of the International Zinc Association, Pharmanova, and the Zambian Ministries of Health and Education.
The collaboration was formally celebrated during a ceremony in Lusaka with the Zambian Ministry of Health, Pharmanova Zambia Limited, and IZA represented by Environment Health & Sustainability Director Dr. Eric Van Genderen.
IZA and Pharmanova have united in an effort to scale up treatment for childhood diarrhea using zinc, an essential micronutrient that strengthens immune systems and reduces the severity and duration of diarrheal disease. The need is urgent: more than 30% of Zambia’s population is zinc‑deficient, leaving children especially vulnerable to diarrhea, pneumonia, and malaria. Globally, 116,000 children are estimated to die from zinc deficiency related issues every year.
Through this partnership, every dollar donated to Zinc Saves Kids will directly support the distribution of Kit Yamoyo, the “Kit of Life,” which includes oral rehydration salts (ORS) and a ten‑day supply of zinc tablets. Zinc and ORS are recommended by the World Health Organization for the treatment of diarrhea. Each kit provides a complete treatment for diarrhea and helps prevent future illness.
“IZA is thrilled to work with Pharmanova to address zinc deficiency, which weakens the immune systems of at‑risk children and leaves them vulnerable to diarrhea, pneumonia, and malaria,” said Dr. Van Genderen. “Zinc is critical to healthy mental and physical development, and this partnership is an important step toward improving child health in Zambia.”
The first tranche of donations already has supplied 50,000 zinc and oral rehydration kits to Zambian children. Distribution is being conducted through the government’s Healthy Learners program, which operates in schools nationwide and focuses on reaching rural and underserved communities.
Pharmanova, established in 1980, developed Kit Yamoyo to combat childhood diarrhea and has previously partnered with agencies including USAID and UNICEF to expand access to essential medicines.
“There is a great need for Kit Yamoyo across Zambia and beyond, so we are pleased to have the opportunity to work with the International Zinc Association, which has a long history of addressing zinc deficiency worldwide,” said Mohammed Umar, CEO of Pharmanova. “We envision a long and fruitful partnership with Zinc Saves Kids.”
Launched in 2010, Zinc Saves Kids works to raise awareness of global zinc deficiency and supports programs focused on supplementation, food fortification, and treatment. The partnership with Pharmanova marks a significant expansion of the initiative’s reach, which has previously raised more than $4 million to provide life-saving research, education, and treatment related to zinc.
About the International Zinc Association
The International Zinc Association (IZA) is the only organization dedicated exclusively to the interests of zinc and its users. As the voice of the global zinc industry, IZA provides global leadership, coordination, and value on strategic issues for the zinc industry, including market development, license to operate, communications, and sustainability.
About Pharmanova Zambia Limited
Pharmanova Zambia Limited has been at the forefront of the Zambian pharmaceutical manufacturing industry since 1980, providing a diverse range of essential products aimed at enhancing health, hygiene, and overall well-being for Zambia and the region. Pharmanova operates three manufacturing sites strategically located in Lusaka, the capital city of Zambia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260121178091/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lehman Brothers Treasury Announces the Successful Sale of its Remaining Intercompany Claim against Lehman Brothers Holdings Inc.18.8.2026 21:15:00 CEST | Press release
In connection with its previously announced final wind-down, Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”), through its U.S. counsel Herbert Smith Freehills Kramer (US) LLP, announced that its placement agent, Seaport Loan Products LLC, successfully closed the sale of LBT’s remaining $19.6 billion Class 4A intercompany claim against Lehman Brothers Holdings Inc. The net proceeds of the sale, together with certain available cash (but after deducting various sale-related and other administrative costs and expenses), will be used to fund a final distribution to the holders of LBT’s existing notes, after which such existing notes will be canceled and LBT shall be fully wound down. As a result, LBT will cease to exist. LBT expects the final distribution to occur in the course of October 2026 and the wind down to have been completed before the end of 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260818004215/en/
GenBio AI Builds First World Model of the Human Cell18.8.2026 15:00:00 CEST | Press release
First-of-its-kind system simulates human cell behavior across the full biological hierarchy, from DNA and RNA through protein to the whole-cell level GenBio AI ('GenBio') is an AI for Science company co-founded by Nobel Laureate David Baker, leading AI scientist Eric Xing, and other prominent life science and artificial intelligence researchers from Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute, and other research institutions. Today, the company introduced AIDO Cell, its virtual cell world model — the first system capable of simulating a human cell, both in its natural state and in response to drugs and other interventions, across its full biological hierarchy, from DNA and RNA through protein to the whole-cell level. A Key First in Biological and Medical Sciences: Full-hierarchy virtual cell simulation has been widely identified as a key milestone in computational biology. Compared to the previous efforts by
Xsolla Partner Network Expands Verified Creator Partnerships and Unifies Campaign Management Ahead of gamescom 202618.8.2026 15:00:00 CEST | Press release
Developers Gain Vetted Creator Partnerships And A Single Campaign Workflow, Managed From The Publisher Account They Already Use Xsolla, a global video game commerce company, today announced an expansion of the Xsolla Partner Network ahead of gamescom 2026 in Cologne, giving game developers a simpler, more reliable way to grow their games through creators. The creator platform now lives within Xsolla Publisher Account, where developers already run their business, with verified creator onboarding and a redesigned and unified campaign workflow. Flat-fee campaigns, a new guaranteed payment option alongside revenue share, and data-driven creator recommendations are coming soon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818140062/en/ Graphic: Xsolla Xsolla Partner Network gives developers one place to launch, manage, track, and report on creator campaigns while Xsolla handles payments, payouts, taxes, and compliance.Verifi
KOCCA to Showcase 13 Korean Game Companies at ‘Gamescom 2026’ with PC, Mobile, and VR Lineups18.8.2026 14:48:00 CEST | Press release
- Featuring a diverse lineup of roguelike deckbuilders, AI-powered rhythm education, and cooperative horror games - Ranging from new titles based on the popular animated IP ‘LARVA’ to real-time K-POP dance coaching content - Hands-on experience available August 26–28 at the Korea Joint Pavilion B2B Hall, Koelnmesse, Booth Hall 3.2 C-050g–D051g The Korea Creative Content Agency (KOCCA) announced that 13 Korean game companies will gather under one roof at Gamescom 2026, Europe’s largest game show, held in Cologne, Germany, from August 26 to 28 (B2B, 09:00~20:00). Located in Booth Hall 3.2 C-050g–D051g, the Korea Joint Pavilion offers visitors hands-on experiences with an expansive lineup of titles, ranging from PC and mobile games to VR-powered titles across diverse genres. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818271881/en/ KOCCA will bring 13 Korean game companies to Gamescom 2026 in Cologne, Germany (Image: KOCC
SLB to Support Offshore Production Restoration for Brunei Shell Petroleum18.8.2026 14:06:00 CEST | Press release
Integrated execution model combines multiple disciplines to improve recovery from mature offshore assets Global energy technology company SLB (NYSE: SLB) today announced it has been awarded a contract by Brunei Shell Petroleum (BSP) to support production restoration from shut-in wells across multiple offshore fields. The contract scope spans subsurface evaluation, well candidate selection, engineering and offshore execution. Project management, intervention services, monitoring, metering and marine logistics are integrated within a single coordinated execution model designed to support efficient production restoration. “Building on our long collaboration in the region, this contract reflects a shared commitment to maximizing value from existing offshore resources,” said Gokhan Yarim, senior vice president of Integration, SLB. “Together with BSP, we are combining SLB’s production expertise and integrated execution capabilities to help restore production from shut-in wells, increase reco
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom